Axoltis Pharma

Axoltis Pharma Overview

Founded 2003
Founded
Status Private
Employees 2
Employees
Latest Deal Type Series A
Latest Deal Amount $1.24M
Latest Deal Amount
Investors 7

Axoltis Pharma General Information

Description

Developer of first-in-class innovative drugs designed to treat patients suffering from traumatic or severe neurological disorders. The company's drugs support neural repair in order to treat traumatic or severe degenerative disorders of the central nervous system faced with high unmet medical needs, enabling patients with the extension of its potential to the treatment of neurodegenerative diseases and o improve the patients' functional recovery and quality of life.

Contact Information

Website
Formerly Known As
Neuronax
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 15 - 17, Rue du Pré de la Reine
  • 63100 Clermont-Ferrand
  • France
+33 04 00 00 00 00
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Axoltis Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 19-Dec-2014 $1.24M 00.000 Completed Profitable
1. Grant 01-Oct-2012 00000 Completed Generating Revenue

Axoltis Pharma Executive Team (6)

Name Title Board Seat Contact Info
Yann Godfrin Ph.D Chief Executive Officer & Chairman
Manuel Blanc Ph.D Chief Scientific Officer
Pierre-Yves Simonin Co-Founder

3 Former Executives

Axoltis Pharma Board Members (3)

Name Representing Role Since
François Miceli Sofimac Investment Managers Supervisory Board Member 000 0000
Philippe du Mesnil Self Supervisory Board Member 000 0000
Yann Godfrin Ph.D Axoltis Pharma Chief Executive Officer & Chairman 000 0000

Axoltis Pharma Investors (7)

To view Axoltis Pharma‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Angelor Capitale Angel Group Minority 000 0000 000000 0
Auvergne Business Angels Angel Group Minority 000 0000 000000 0
FaDiese Venture Capital Minority 000 0000 000000 0
Individual Investor Angel (individual) Minority 000 0000 000000 0
JEREMIE Auvergne Venture Capital Minority 000 0000 000000 0

Ready to get started?

Request a free trial